Answers are grounded in this paper and cite their sources.
Reveals FPR1 signaling worsens MASH through proinflammatory S100A4 and S100A11 in myeloid cells, suggesting new treatment pathways.
FPR1 in myeloid cells is a crucial factor associated with the inflammatory response; however, whether FPR1 signaling affects MASH development remains largely unknown.In this study, we demonstrated that Fpr1 deficiency in myeloid cells and administration of an FPR1 inhibitor robustly limit MASH-related fibrosis, which is closely related with the downregulation of proinflammatory S100A4 and S100A11.In addition, neutrophil-derived ANXA1 elevates the expression of S100A4 and S100A11 in neutrophils and macrophages by activating FPR1 signaling, suggesting that the ANXA1-FPR1-S100A4/A11 axis plays an important role in worsening MASH. Highlights: Myeloid cell-specific Fpr1 deficient mice are more resistant to MASH. Administration of FPR1 inhibitor robustly ameliorates MASH. The ANXA1-FPR1 axis elevates the expression of proinflammatory S100A4 and S100A11.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: